Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arrowhead Pharmaceuticals Inc ARWR

Healthcare Biotechnology
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. The Company's Targeted RNAi Molecule (TRiMTM) platform... see more

Recent & Breaking News (NDAQ:ARWR)

Arrowhead Pharmaceuticals Announces Presentations at The International Liver Congress™

Business Wire April 5, 2017

Arrowhead Pharmaceuticals Adopts Stockholder Rights Agreement

Business Wire March 23, 2017

Research Reports Coverage on Biotech Stocks -- Anthera Pharma, Arrowhead Pharma, Pacific Biosciences of California, and Conatus Pharma

PR Newswire February 27, 2017

Arrowhead Reports Fiscal 2017 First Quarter Results

Business Wire February 6, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results

Business Wire January 30, 2017

Robbins Arroyo LLP: Arrowhead Pharmaceuticals, Inc. (ARWR) Misled Shareholders According to a Recently Filed Class Action

Business Wire January 20, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Arrowhead Pharmaceuticals, Inc. and Certain Officers – ARWR

GlobeNewswire January 13, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – ARWR

GlobeNewswire January 13, 2017

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Arrowhead Pharmaceuticals, Inc. (ARWR) and Lead Plaintiff Deadline: January 16, 2017

GlobeNewswire January 12, 2017

15 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  January 11, 2017

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017 – ARWR

Business Wire January 9, 2017

15 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  January 9, 2017

Arrowhead Provides Response to New Minority Shareholder Announcement

Business Wire January 9, 2017

DEADLINE ALERT: Brower Piven Reminds Investors Of The January 16, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In Arrowhead Pharmaceuticals, Inc. To Contact The Firm

Business Wire January 7, 2017

ARWR LOSS NOTICE: Rosen Law Firm Reminds Arrowhead Pharmaceuticals, Inc. Investors of Important Deadline in Class Action - ARWR

GlobeNewswire January 6, 2017

ARWR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Shareholders of a Class Action Involving Arrowhead Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017

Business Wire January 3, 2017

Research Reports Initiation on Biotech Stocks -- Arrowhead Pharma, Intra-Cellular Therapies, Synthetic Biologics, and CoLucid Pharma

PR Newswire January 3, 2017

ARWR INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Shareholders of Commencement of a Class Action Involving Arrowhead Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 17, 2017

PR Newswire December 27, 2016

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Arrowhead Pharmaceuticals, Inc. - ARWR

GlobeNewswire December 23, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Arrowhead Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 17, 2017

Business Wire December 21, 2016